Shannon John Patrick Jr — SEC Form 4 filings
SEC reporting owner CIK 1553595. 9 Form 4 filings on record with FilingPulse; latest filed 2026-08-21.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-01-31 to 2026-08-21. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 2 filings — 48,149 shares, $349,658 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 33.
- Largest priced transaction: sale of 24,907 shares @ $7.08 ($176,257) in Xeris Biopharma Holdings, Inc., filed 2026-01-06.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Xeris Biopharma Holdings, Inc. (XERS) | See Remarks, Director | 9 | — | 2 legs · 48,149 sh · $349,658 | 33 |
Form 4 filings — Shannon John Patrick Jr
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-21 | 4 | Xeris Biopharma Holdings, Inc. (XERS) | Tax withholding (F): 36,645 @ $8.08 | EDGAR |
| 2026-02-02 | 4 | Xeris Biopharma Holdings, Inc. (XERS) | Grant/award (A): 478,436 @ $0 · Tax withholding (F): 118,134 @ $7.36 · Tax withholding (F): 111,621 @ $7.36 · Tax withholding (F): 110,750 @ $7.36 · Grant/award (A): 639,639 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Xeris Biopharma Holdings, Inc. (XERS) | Sale (S): 24,907 @ $7.08 · Option exercise (M): 64,265 @ $1.55 · Option exercise (M): 25,136 @ $1.55 · Option exercise (M): 2,900 @ $3.94 · Option exercise (M): 64,265 (derivative) @ $0 · Option exercise (M): 25,136 (derivative) @ $0 · +1 more | EDGAR |
| 2025-11-17 | 4 | Xeris Biopharma Holdings, Inc. (XERS) | Option exercise (M): 8,970 @ $1.55 · Sale (S): 23,242 @ $7.46 · Option exercise (M): 87,100 @ $1.55 · Option exercise (M): 8,970 (derivative) @ $0 · Option exercise (M): 87,100 (derivative) @ $0 | EDGAR |
| 2025-08-04 | 4 | Xeris Biopharma Holdings, Inc. (XERS) | Tax withholding (F): 36,918 @ $5.38 | EDGAR |
| 2025-02-03 | 4 | Xeris Biopharma Holdings, Inc. (XERS) | Tax withholding (F): 110,750 @ $3.56 · Tax withholding (F): 110,750 @ $3.56 · Grant/award (A): 800,000 @ $0 · Grant/award (A): 600,000 (derivative) @ $0 | EDGAR |
| 2025-01-07 | 4 | Xeris Biopharma Holdings, Inc. (XERS) | Tax withholding (F): 39,443 @ $3.61 | EDGAR |
| 2024-08-02 | 4 | Xeris Biopharma Holdings, Inc. (XERS) | Grant/award (A): 250,000 @ $0 · Tax withholding (F): 15,692 @ $2.11 · Tax withholding (F): 7,497 @ $2.11 · Tax withholding (F): 41,334 @ $1.12 · Tax withholding (F): 23,414 @ $1.26 · Tax withholding (F): 9,880 @ $1.24 · +4 more | EDGAR |
| 2024-01-31 | 4 | Xeris Biopharma Holdings, Inc. (XERS) | Grant/award (A): 750,000 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1553595 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →